M3 Advisory Group LLC Sells 309 Shares of Colgate-Palmolive Company $CL

M3 Advisory Group LLC trimmed its holdings in Colgate-Palmolive Company (NYSE:CL) by 9.3% during the second quarter, Holdings Channel reports. The institutional investor owned 3,001 shares of the company’s stock after selling 309 shares during the quarter. M3 Advisory Group LLC’s holdings in Colgate-Palmolive were worth $273,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Westend Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 140 shares during the last quarter. Cornerstone Planning Group LLC raised its holdings in shares of Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after purchasing an additional 287 shares during the last quarter. Saudi Central Bank purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $29,000. Ransom Advisory Ltd purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $37,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $77.99 on Monday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The company has a market capitalization of $63.03 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 4.29 and a beta of 0.34. Colgate-Palmolive Company has a 52-week low of $77.09 and a 52-week high of $102.61. The company has a 50-day simple moving average of $82.56 and a 200 day simple moving average of $87.84.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the business earned $0.91 earnings per share. On average, research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Wall Street Analyst Weigh In

Several analysts have recently commented on CL shares. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a report on Friday. Barclays lowered their target price on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Bank of America lowered their target price on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Citigroup lowered their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Finally, Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a report on Thursday, September 25th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.